Impact of Social Determinants of Health on Psychotropic Long-Acting Injectable Access and Administration | Grant Supported by Otsuka America Pharmaceutical, Inc. and Lundbeck

Sign in (or create a FREE account) to register or access your existing registration.

This session is a free, grant-supported continuing education webinar.

Social determinants of health play a critical role in the access to and administration of psychotropic long-acting injectables (LAIs). Factors like socioeconomic status, geographic location, and cultural beliefs shape patient access to these essential mental health services, impacting treatment outcomes. Participants will gain insight into the barriers to effective psychotropic LAI use and explore current research and innovative programs aimed at overcoming these obstacles. This webinar highlights practical examples and successful strategies for improving LAI access and adherence. Psychiatric pharmacists will be equipped with the insights needed to advocate for and contribute to systemic changes that enhance mental health care delivery, understanding the broader social context of their patients' care.

This free grant-supported webinar is presented as part of the 2024 Summit.

Go to the 2024 Summit schedule

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Course Requirements

To receive ACPE credit for this session, you must:

  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the evaluation at the end of the activity.
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Faculty Information

Robert G. Sise, MD, MBA, MPH
View biographical information
Robert G. Sise, MD, MBA, MPH
Chief Executive Officer and Co-Founder of 406 Recovery
 
Throughout his work, Dr. Sise emphasizes meeting patients where they are at in their willingness to change. Prior to co-founding 406 Recovery, he co-founded and served as chief medical officer of the greater-Montana region’s largest psychiatric practice to ensure more Montanans have access to quality psychiatric treatment services and crisis care. He also served as chief executive officer of a joint venture with the Montana Hospital Association to provide emergency psychiatry consultation services to hospitals across the state. Dr. Sise started providing care to Montanans when he joined Billings Clinic and founded the organization’s first addiction treatment clinic. Before leaving Billings Clinic in 2021, he served as Medical Director of Montana’s first EmPATH Unit, led the consult-liaison psychiatry service and created a virtual urgent care service. He has lectured on substance use disorder screening, diagnosis and treatment at both state and regional conferences. Dr. Sise is board certified in addiction medicine as well as general and addiction psychiatry.

Learning Objectives

  1. Identify key social determinants of health that influence access to and administration of psychotropic LAIs, such as socioeconomic status, geographic location, and cultural factors.
  2. Explain the impact of social determinants of health on psychotropic LAI access and treatment outcomes.
  3. Describe successful programs and initiatives that address social determinants of health to improve access and adherence to psychotropic LAIs.

Continuing Education Credit and Disclosures

Activity Dates: 10/10/2024 - 12/31/2025
ACPE Contact Hours: 1
ACPE Number: 0284-0000-24-066-H04-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

View disclaimer and disclosure of off-label use

Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

View fair balance and integrity statement

It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.